NUP160
Nuclear pore complex protein Nup160
Also known as: FLJ22583, KIAA0197, NU160_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12769
- Gene
- NUP160
- Ensembl
- ENSG00000030066
- Chromosome
- 11
- Canonical length
- 1436 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters
OverviewNCBI Gene
A structural constituent of nuclear pore. Involved in mRNA export from nucleus and nephron development. Located in kinetochore and nuclear envelope. Part of nuclear pore outer ring. Implicated in nephrotic syndrome type 19. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1436 residues, UniProt reviewed canonical sequence.
>Q12769|NUP160
1 MLHLSAAPPA PPPEVTATAR PCLCSVGRRG DGGKMAAAGA LERSFVELSG AERERPRHFR
61 EFTVCSIGTA NAVAGAVKYS ESAGGFYYVE SGKLFSVTRN RFIHWKTSGD TLELMEESLD
121 INLLNNAIRL KFQNCSVLPG GVYVSETQNR VIILMLTNQT VHRLLLPHPS RMYRSELVVD
181 SQMQSIFTDI GKVDFTDPCN YQLIPAVPGI SPNSTASTAW LSSDGEALFA LPCASGGIFV
241 LKLPPYDIPG MVSVVELKQS SVMQRLLTGW MPTAIRGDQS PSDRPLSLAV HCVEHDAFIF
301 ALCQDHKLRM WSYKEQMCLM VADMLEYVPV KKDLRLTAGT GHKLRLAYSP TMGLYLGIYM
361 HAPKRGQFCI FQLVSTESNR YSLDHISSLF TSQETLIDFA LTSTDIWALW HDAENQTVVK
421 YINFEHNVAG QWNPVFMQPL PEEEIVIRDD QDPREMYLQS LFTPGQFTNE ALCKALQIFC
481 RGTERNLDLS WSELKKEVTL AVENELQGSV TEYEFSQEEF RNLQQEFWCK FYACCLQYQE
541 ALSHPLALHL NPHTNMVCLL KKGYLSFLIP SSLVDHLYLL PYENLLTEDE TTISDDVDIA
601 RDVICLIKCL RLIEESVTVD MSVIMEMSCY NLQSPEKAAE QILEDMITID VENVMEDICS
661 KLQEIRNPIH AIGLLIREMD YETEVEMEKG FNPAQPLNIR MNLTQLYGSN TAGYIVCRGV
721 HKIASTRFLI CRDLLILQQL LMRLGDAVIW GTGQLFQAQQ DLLHRTAPLL LSYYLIKWGS
781 ECLATDVPLD TLESNLQHLS VLELTDSGAL MANRFVSSPQ TIVELFFQEV ARKHIISHLF
841 SQPKAPLSQT GLNWPEMITA ITSYLLQLLW PSNPGCLFLE CLMGNCQYVQ LQDYIQLLHP
901 WCQVNVGSCR FMLGRCYLVT GEGQKALECF CQAASEVGKE EFLDRLIRSE DGEIVSTPRL
961 QYYDKVLRLL DVIGLPELVI QLATSAITEA GDDWKSQATL RTCIFKHHLD LGHNSQAYEA
1021 LTQIPDSSRQ LDCLRQLVVV LCERSQLQDL VEFPYVNLHN EVVGIIESRA RAVDLMTHNY
1081 YELLYAFHIY RHNYRKAGTV MFEYGMRLGR EVRTLRGLEK QGNCYLAALN CLRLIRPEYA
1141 WIVQPVSGAV YDRPGASPKR NHDGECTAAP TNRQIEILEL EDLEKECSLA RIRLTLAQHD
1201 PSAVAVAGSS SAEEMVTLLV QAGLFDTAIS LCQTFKLPLT PVFEGLAFKC IKLQFGGEAA
1261 QAEAWAWLAA NQLSSVITTK ESSATDEAWR LLSTYLERYK VQNNLYHHCV INKLLSHGVP
1321 LPNWLINSYK KVDAAELLRL YLNYDLLEEA VDLVSEYVDA VLGKGHQYFG IEFPLSATAP
1381 MVWLPYSSID QLLQALGENS ANSHNIALSQ KILDKLEDYQ QKVDKATRDL LYRRTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NUP160 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- thymus: 30 nTPM
- tonsil: 21 nTPM
- bone marrow: 20 nTPM
- placenta: 20 nTPM
- lymph node: 20 nTPM
- ovary: 18 nTPM
Single-cell type
- renal collecting duct intercalated cells: 117 nCPM
- choroid plexus epithelial cells: 101 nCPM
- distal convoluted tubule cells: 95 nCPM
- oligodendrocyte progenitor cells: 89 nCPM
- loop of henle epithelial cells: 75 nCPM
- oligodendrocytes: 75 nCPM
Immune cell
- plasmacytoid DC: 17 nTPM
- memory B-cell: 16 nTPM
- naive CD4 T-cell: 16 nTPM
- naive B-cell: 16 nTPM
- MAIT T-cell: 14 nTPM
- eosinophil: 14 nTPM
Brain region
- cerebellum: 22 nTPM
- white matter: 20 nTPM
- choroid plexus: 20 nTPM
- basal ganglia: 15 nTPM
- medulla oblongata: 15 nTPM
- midbrain: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NUP160.
Disease | AllUniProt
Conditions NUP160 is implicated in, by any mechanism.
- Nephrotic syndrome 19 (NPHS19) MIM:618178
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 473 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Nephrotic syndrome, type 19
- NUP160-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.04
- DepMap mean gene effect
- -1.35
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nucleoporin Nup120/160
- NUP160, middle TPR domain
- NUP160, C-terminal TPR domain
- NUP160, helical domain
- Nucleoporin Nup120/160, beta-propeller domain
- Nucleoporin Nup120/160, beta-propeller domain
- Nucleoporin NUP160, helical domain
- Nup160 C-terminal TPR
- NUP160/120 middle TPR
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NUP160 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NUP160 as an antibody target. Whether an autoantibody or antibody against NUP160 could matter depends on whether native NUP160 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NUP160 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NUP160 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...